Legal & General Group Plc - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$195,000
+68.1%
32,2600.0%0.00%
Q3 2019$116,000
+70.6%
32,260
+27.6%
0.00%
Q2 2019$68,000
-9.3%
25,2750.0%0.00%
Q1 2019$75,000
+87.5%
25,2750.0%0.00%
Q4 2018$40,000
-49.4%
25,275
+18.3%
0.00%
Q3 2018$79,000
+49.1%
21,357
+13.0%
0.00%
Q2 2018$53,000
-40.4%
18,903
-21.2%
0.00%
Q1 2018$89,000
-33.6%
23,987
-48.2%
0.00%
Q4 2017$134,000
-35.3%
46,3450.0%0.00%
Q3 2017$207,000
+5.6%
46,345
+8.0%
0.00%
Q2 2017$196,000
+64.7%
42,900
+53.8%
0.00%
Q1 2017$119,000
+1.7%
27,900
-1.5%
0.00%
Q4 2016$117,000
-14.0%
28,327
+65.1%
0.00%
Q3 2016$136,000
-3.5%
17,161
-4.7%
0.00%
Q2 2016$141,000
+0.7%
18,0100.0%0.00%
Q1 2016$140,000
-15.7%
18,010
+15.7%
0.00%
Q4 2015$166,000
+61.2%
15,5670.0%0.00%
Q3 2015$103,000
-16.9%
15,567
+7.4%
0.00%
Q2 2015$124,000
-15.6%
14,5010.0%0.00%
Q1 2015$147,000
-18.8%
14,5010.0%0.00%
Q4 2014$181,000
+16.0%
14,501
-3.1%
0.00%
Q3 2014$156,00014,9590.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders